RICHARD NOEL: Open Payments
NPI 1225058852 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 50 payments from 8 companies in 2025. Trend: 2023 $890 · 2024 $1,603 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $287 |
| Otsuka America Pharmaceutical, Inc. | 14 | $225 |
| Neurocrine BioSciences, Inc. | 10 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $157 |
| Alkermes, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Corium, LLC | 1 | $3 |
Products named: COBENFY, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
